plerixafor has been researched along with Aortic Aneurysm, Abdominal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allaire, E; Dai, J; Franck, G; Gervais, M; Michineau, S; Wagner-Ballon, O | 1 |
1 other study(ies) available for plerixafor and Aortic Aneurysm, Abdominal
Article | Year |
---|---|
Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Benzylamines; Bone Marrow Transplantation; Calcium Chloride; Chemokine CXCL12; Chemotaxis; Cyclams; Disease Models, Animal; Green Fluorescent Proteins; Guinea Pigs; Heterocyclic Compounds; Heterografts; Humans; Inflammation Mediators; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Smooth Muscle; Rats; Rats, Inbred F344; Receptors, CXCR4; Time Factors; U937 Cells | 2014 |